Inventor · disambiguated record
Daniel W. Drolet
Also filed as: DROLET DANIEL · DROLET DANIEL W
12 granted patents·9 pending applications·231 citations·filing 1998–2023
91Inventor score
Top patents by PatentIndex Score
21 records- 0197US10221421B2Post-selec modification methodsSOMALOGIC INC·Filed 2017·Granted Mar 5, 2019·39 cites·6 claims
- 0293US6544776B1Nucleic acid ligand diagnostic biochipSOMALOGIC INC·Filed 1998·Granted Apr 8, 2003·141 cites·18 claims
- 0387US6387635B12′-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligandsGILEAD SCIENCES INC·Filed 2001·Granted May 14, 2002·12 cites·6 claims
- 0486US9701967B2Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditionsSOMALOGIC INC·Filed 2016·Granted Jul 11, 2017·4 cites·10 claims
- 0584US6673553B22′-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligandsGILEAD SCIENCES INC·Filed 2002·Granted Jan 6, 2004·8 cites·3 claims
- 0682US9410156B2Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditionsSOMALOGIC INC·Filed 2013·Granted Aug 9, 2016·4 cites·24 claims
- 0779US9695424B2PDGF and VEGF aptamers having improved stability and their use in treating PDGF and VEGF mediated diseases and disordersSOMALOGIC INC·Filed 2014·Granted Jul 4, 2017·3 cites·9 claims
- 0878US9994857B2PDGF and VEGF aptamers having improved stability and their use in treating PDGF and VEGF mediated diseases and disordersSOMALOGIC INC·Filed 2017·Granted Jun 12, 2018·2 cites·3 claims
- 0975US10544419B2PDGF and VEGF aptamers having improved stability and their use in treating PDGF and VEGF mediated diseases and disordersSOMALOGIC INC·Filed 2018·Granted Jan 28, 2020·1 cites·8 claims
- 1069US6280943B12′-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligandsGILEAD SCIENCES INC·Filed 1999·Granted Aug 28, 2001·17 cites·13 claims
- 1166US2023093170A1Nucleic Acid Compounds for Binding to Complement Component 3 ProteinSOMALOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 1265US11208663B2Post-selex modification methodsSOMALOGIC INC·Filed 2019·Granted Dec 28, 2021·0 cites·9 claims
- 1362US2025180571A1Methods for Sample Quality AssessmentSOMALOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 1462US2025231198A1Methods for Sample Quality AssessmentSOMALOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 1562US2025052766A1Methods for Sample Quality AssessmentSOMALOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 1662US2025093355A1Methods for Sample Quality AssessmentSOMALOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 1762US2025208119A1Methods for Sample Quality AssessmentSOMALOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 1861US2004053271A12'-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligandsGILEAD SCIENCES INC·Filed 2003·Application pending·0 cites
- 1952US11466275B2Nucleic acid compounds for binding to complement component 3 proteinSOMALOGIC OPERATING CO INC·Filed 2015·Granted Oct 11, 2022·0 cites·24 claims
- 2048US2021317456A1Nucleic Acid Compounds for Binding Immunoglobulin GSOMALOGIC INC·Filed 2019·Application pending·0 cites
- 2143US2022178940A1Reducing Intersample Analyte Variability in Complex Biological MatricesSOMALOGIC INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel W. Drolet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →